Safety and efficacy of the intra-bone marrow cord blood transplantatio
Phase 1
- Conditions
- hematological diseases
- Registration Number
- JPRN-UMIN000006175
- Lead Sponsor
- niversity of Tsukuba, Department of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse effects related intra-bone injection of cord-blood cells, engraftment rate of netrophil and platelet
- Secondary Outcome Measures
Name Time Method Regimen-related toxicity, disease-free survival, over-all survival, non-relapse mortality, relapse rate, incidence of infection, rate and severity of acute GVHD, number of neutrophil and platelet on day 50 and day 100